James Cho

James Cho is the SVP Finance and Chief Accounting Officer at Gritstone bio, a clinical stage company developing next-generation vaccines for cancer and infectious disease. With a background in finance and accounting, James has held positions such as Vice President at UNITY Biotechnology and Corporate Controller at various companies like Kodiak Sciences Inc. and KaloBios Pharmaceuticals, Inc. James has also worked as an Associate Director of Finance & Business Operations at Pfizer and gained experience in consulting at companies like Capgemini and Siegfried Group LLP. James holds an MBA in Finance from USC Marshall School of Business and a BS in Accounting from the University of Utah.